Condition
Mesothelioma
Estimated Enrollment: 32
Age Group: 18 Years and older (Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Open Label|Primary Purpose: Treatment
Study ID Numbers: CDR0000401795|U10CA021115|E1B03
Study First Received: January 7, 2005
Last Updated: November 30, 2012
Estimated Primary Completion Date: September 2009
Primary Outcome Measures:
Best Overall Response by RECIST Criteria (Version 1.0)|Overall Survival|Progression-Free Survival
Sponsors and Collaborators:
Eastern Cooperative Oncology Group|National Cancer Institute (NCI)|North Central Cancer Treatment Group
Website Link: https://ClinicalTrials.gov/show/NCT00101283
